ABSTRACT
Benzimidazole (BZI) is an important pharmacophore privileged structure in medicinal chemistry. It is a heterocyclic aromatic organic compound which plays an important role in medical field owing to diverse pharmacological activities such as antimicrobial, antiviral, antidiabetic, antihypertensive, antiulcer, analgesic, antifungal, and anticancer activity. Hypertension is the chronic medical condition which is mainly responsible for cardiovascular diseases today. Targeting the AT1 receptors of Angiotensin-II with nonpeptide-based drugs which are otherwise called angiotensin receptor blockers (ARBs), led to the control of hypertension. The current chapter indicated the progress of BZI in exhibiting antihypertensive activity.
